BONST
AZN icon

Bank of Nova Scotia Trust’s AstraZeneca AZN Stock Holding History

Bank of Nova Scotia Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,391
Closed -$94K – 153
2017
Q3 		$94K Buy
+1,391
New +$87.9K 0.01% 184

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Nova Scotia Trust's AZN Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 1,391 shares — an estimated $94K sold.

Bank of Nova Scotia Trust first reported a position in AZN in Q3 2017 and held it in 1 quarter. The position peaked at $94K in Q3 2017. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • Bank of Nova Scotia Trust reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 1,391 AstraZeneca shares in Q4 2017, an estimated $94K.
  • Bank of Nova Scotia Trust first reported a position in AstraZeneca in Q3 2017 and held it in 1 quarter.
  • Bank of Nova Scotia Trust's AstraZeneca position peaked at $94K in Q3 2017.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.